Newly diagnosed chronic obstructive pulmonary disease: Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease

Respiration

Volumn 70, Issue 1, 2003, Pages 67-75

  Kornmann, Oliver ^a   Beeh, K M ^a   Beier, J ^a   Geis, U P ^a   Ksoll, M ^b   Buhl, R ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Pulmonary Practice   (Germany)

Author keywords

Chronic obstructive pulmonary disease; Epidemiology; Global Initiative for Obstructive Lung Disease guidelines; Pulmonary function tests

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SMOKING; SMOKING CESSATION; SPIROMETRY; SPUTUM; SYMPTOM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GAS ANALYSIS; COUGH; DATA INTERPRETATION, STATISTICAL; DYSPNEA; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; GERMANY; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; PRACTICE GUIDELINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SEX FACTORS; SKIN TESTS; SMOKING; SPUTUM; TIME FACTORS;

EID: 0037282905     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068417     Document Type: Article

References (30)

1. Senior RM, Anthonisen NR: Chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:S139-S147.
2. Petty TL: Scope of the COPD problem in North America: Early studies of prevalence and NHANES III data: Basis for early identification and intervention. Chest 2000;117:326S-331S.
3. Pauwels RA, Buist AS, Calverley PMA, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001;163:1256-1276.
4. Chen JC, Mannino DM: Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med 1999;5:93-99.
5. Rennard SI: Inflammation and repair processes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:S12-S16.
6. Elkington H, White P, Higgs R, et al: GP's views of discussion of prognosis in severe COPD. Fam Pract 2001;18:440-444.
7. Viegi G, Scognamiglio A, Baldacci S, et al: Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001;68:4-19.
8. Anto JM, Vermeire P, Vestbo J, et al: Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001;17:982-994.
9. Montnemery P, Adelroth E, Heuman K, et al: Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med 1998;92:1337-1345.
10. Sahebjami H, Sathianpitayakul E: Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:886-890.
11. Terr AI: Skin prick testing; in Stites DP, Terr AI (eds): Basic and Clinical Immunology. East Norwalk, Appleton & Lange, 1991, p 375.
12. American Thoracic Society: Standardization of Spirometry - 1987 Update. Am Rev Respir Dis 1987;136:1285-1298.
13. Quanjer PH, Tammeling GJ, Cotes JE, et al: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993;6(suppl 16):5-40.
14. National Heart, Lung and Blood Institute: Guidelines for the diagnosis and management of asthma. NIH Publication 1998, No 98-4051.
15. Gijsbers van Wijk CM, Huisman H, Kolk AM: Gender differences in physical symptoms and illness behavior. A health diary study. Soc Sci Med 1999;49:1061-1074.
16. Mannino DM, Brown C, Giovino CA: Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997;156:814-818.
17. Thun MJ, Lally CA, Flannery JT, et al: Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997;89:1580-1586.
18. Mahler DA, Rosiello RA, Harver A, et al: Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis 1987;135:1229-1233.
19. Wolkove N, Dajczman E, Colacone A, et al: The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest 1989;96:1247-1251.
20. Kikuchi Y, Okabe S, Tamura G, et al: Chemo-sensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 1994;330:1329-1334.
21. Ebgelen MP, Schols AM, Lamers RJ, et al: Different patterns of tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr 1999;18:275-280.
22. McCool FD, Leith DE: Pathophysiology of cough. Clin Chest Med 1987;8:189-195.
23. Kauffmann F, Drouet D, Lellouch J, et al: Twelve years spirometric changes among Paris area workers. Int J Epidemiol 1979;8:201-212.
24. Prescott E, Vestbo J: Socioeconomic status and chronic obstructive pulmonary disease. Thorax 1999;54:737-741.
25. Wouters EFM: Nutrition and metabolism in COPD. Chest 2000;117:274S-280S.
26. Anthonisen NR, Wright EC: Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:814-819.
27. Sherrill DL, Halonen M, Burrows B: Relationships between total serum IgE, atopy, and smoking: A twenty-year follow-up analysis. J Allergy Clin Immunol 1994;94:954-962.
28. Burrows B, Martinez FD, Halonen M, et al: Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271-277.
29. Beeh KM, Ksoll M, Buhl R: Elevation of total serum immunoglobulin E is associated with asthma in non-allergic individuals. Eur Respir J 2000;16:609-614.
30. Weiss ST: Atopy as a risk factor for chronic obstructive pulmonary disease: Epidemiological evidence. Am J Respir Crit Care Med 2000;162:S134-S136.